Chlamydia infections and heart disease linked through antigenic mimicry

Science

Volumn 283, Issue 5406, 1999, Pages 1335-1339

  Bachmaier, Kurt ^a   Nikolaus, Neu ^b   De La Maza, Luis M ^c   Sukumar, Pal ^c   Hessel, Andrew ^a   Penninger, Josef M ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF INNSBRUCK   (Austria)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SEQUENCE; ANTIBODY DETECTION; ANTIGENICITY; ARTICLE; CHLAMYDIA; CHLAMYDIASIS; CROSS REACTION; DISEASE ASSOCIATION; HEART DISEASE; HISTOPATHOLOGY; HUMAN; IMMUNOREACTIVITY; MOLECULAR MIMICRY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADOPTIVE TRANSFER; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, BACTERIAL; AUTOANTIBODIES; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; BACTERIAL OUTER MEMBRANE PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CHLAMYDIA; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CPG ISLANDS; HUMANS; IMMUNIZATION; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; MYOCARDITIS; MYOCARDIUM; MYOSIN HEAVY CHAINS; OLIGODEOXYRIBONUCLEOTIDES; SEQUENCE HOMOLOGY, AMINO ACID;

CHLAMYDIA; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; MURINAE;

EID: 0033605250     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.283.5406.1335     Document Type: Article

References (75)

1. P. W. Wilson et al., Circulation 97, 1837 (1998); J. P. Despres et al., N. Engl. J. Med. 334, 952 (1996); P. G. McGovern et al., ibid., p. 884.
2. P. W. Wilson et al., Circulation 97, 1837 (1998); J. P. Despres et al., N. Engl. J. Med. 334, 952 (1996); P. G. McGovern et al., ibid., p. 884.
3. P. W. Wilson et al., Circulation 97, 1837 (1998); J. P. Despres et al., N. Engl. J. Med. 334, 952 (1996); P. G. McGovern et al., ibid., p. 884.
4. J. Danesh, R. Collins, R. Peto, Lancet 350, 430 (1997); J. M. Ossewaarde, E. J. M. Feskens, A. DeVries, C. E. Vallinga, D. Kromhout, Ipidemiol. Infect. 120, 93 (1998); J. B. Muhlestein et al., J. Am. Coll. Cardiol. 27, 1555 (1996); J. A. Ramirez, Ann. Intern. Med. 125, 979 (1996); J. T. Grayston, C. C. Kuo, L. A. Campbell, E. P. Benditt, Eur. Heart J. 14 (suppl. K), 66 (1993); L. A. Campbell et al., J. Infect Dis. 172, 585 (1995); H. Miettinen et al., Eur. Heart J. 17, 682 (1996); S. Halme et al., ibid. 18, 1095 (1997); M. Odeh, A. Oliven, S. Rauchfleisch, H. Bassan, J. Intern. Med. 229, 289 (1991).
5. J. Danesh, R. Collins, R. Peto, Lancet 350, 430 (1997); J. M. Ossewaarde, E. J. M. Feskens, A. DeVries, C. E. Vallinga, D. Kromhout, Ipidemiol. Infect. 120, 93 (1998); J. B. Muhlestein et al., J. Am. Coll. Cardiol. 27, 1555 (1996); J. A. Ramirez, Ann. Intern. Med. 125, 979 (1996); J. T. Grayston, C. C. Kuo, L. A. Campbell, E. P. Benditt, Eur. Heart J. 14 (suppl. K), 66 (1993); L. A. Campbell et al., J. Infect Dis. 172, 585 (1995); H. Miettinen et al., Eur. Heart J. 17, 682 (1996); S. Halme et al., ibid. 18, 1095 (1997); M. Odeh, A. Oliven, S. Rauchfleisch, H. Bassan, J. Intern. Med. 229, 289 (1991).
6. J. Danesh, R. Collins, R. Peto, Lancet 350, 430 (1997); J. M. Ossewaarde, E. J. M. Feskens, A. DeVries, C. E. Vallinga, D. Kromhout, Ipidemiol. Infect. 120, 93 (1998); J. B. Muhlestein et al., J. Am. Coll. Cardiol. 27, 1555 (1996); J. A. Ramirez, Ann. Intern. Med. 125, 979 (1996); J. T. Grayston, C. C. Kuo, L. A. Campbell, E. P. Benditt, Eur. Heart J. 14 (suppl. K), 66 (1993); L. A. Campbell et al., J. Infect Dis. 172, 585 (1995); H. Miettinen et al., Eur. Heart J. 17, 682 (1996); S. Halme et al., ibid. 18, 1095 (1997); M. Odeh, A. Oliven, S. Rauchfleisch, H. Bassan, J. Intern. Med. 229, 289 (1991).
7. J. Danesh, R. Collins, R. Peto, Lancet 350, 430 (1997); J. M. Ossewaarde, E. J. M. Feskens, A. DeVries, C. E. Vallinga, D. Kromhout, Ipidemiol. Infect. 120, 93 (1998); J. B. Muhlestein et al., J. Am. Coll. Cardiol. 27, 1555 (1996); J. A. Ramirez, Ann. Intern. Med. 125, 979 (1996); J. T. Grayston, C. C. Kuo, L. A. Campbell, E. P. Benditt, Eur. Heart J. 14 (suppl. K), 66 (1993); L. A. Campbell et al., J. Infect Dis. 172, 585 (1995); H. Miettinen et al., Eur. Heart J. 17, 682 (1996); S. Halme et al., ibid. 18, 1095 (1997); M. Odeh, A. Oliven, S. Rauchfleisch, H. Bassan, J. Intern. Med. 229, 289 (1991).
8. J. Danesh, R. Collins, R. Peto, Lancet 350, 430 (1997); J. M. Ossewaarde, E. J. M. Feskens, A. DeVries, C. E. Vallinga, D. Kromhout, Ipidemiol. Infect. 120, 93 (1998); J. B. Muhlestein et al., J. Am. Coll. Cardiol. 27, 1555 (1996); J. A. Ramirez, Ann. Intern. Med. 125, 979 (1996); J. T. Grayston, C. C. Kuo, L. A. Campbell, E. P. Benditt, Eur. Heart J. 14 (suppl. K), 66 (1993); L. A. Campbell et al., J. Infect Dis. 172, 585 (1995); H. Miettinen et al., Eur. Heart J. 17, 682 (1996); S. Halme et al., ibid. 18, 1095 (1997); M. Odeh, A. Oliven, S. Rauchfleisch, H. Bassan, J. Intern. Med. 229, 289 (1991).
9. J. Danesh, R. Collins, R. Peto, Lancet 350, 430 (1997); J. M. Ossewaarde, E. J. M. Feskens, A. DeVries, C. E. Vallinga, D. Kromhout, Ipidemiol. Infect. 120, 93 (1998); J. B. Muhlestein et al., J. Am. Coll. Cardiol. 27, 1555 (1996); J. A. Ramirez, Ann. Intern. Med. 125, 979 (1996); J. T. Grayston, C. C. Kuo, L. A. Campbell, E. P. Benditt, Eur. Heart J. 14 (suppl. K), 66 (1993); L. A. Campbell et al., J. Infect Dis. 172, 585 (1995); H. Miettinen et al., Eur. Heart J. 17, 682 (1996); S. Halme et al., ibid. 18, 1095 (1997); M. Odeh, A. Oliven, S. Rauchfleisch, H. Bassan, J. Intern. Med. 229, 289 (1991).
10. J. Danesh, R. Collins, R. Peto, Lancet 350, 430 (1997); J. M. Ossewaarde, E. J. M. Feskens, A. DeVries, C. E. Vallinga, D. Kromhout, Ipidemiol. Infect. 120, 93 (1998); J. B. Muhlestein et al., J. Am. Coll. Cardiol. 27, 1555 (1996); J. A. Ramirez, Ann. Intern. Med. 125, 979 (1996); J. T. Grayston, C. C. Kuo, L. A. Campbell, E. P. Benditt, Eur. Heart J. 14 (suppl. K), 66 (1993); L. A. Campbell et al., J. Infect Dis. 172, 585 (1995); H. Miettinen et al., Eur. Heart J. 17, 682 (1996); S. Halme et al., ibid. 18, 1095 (1997); M. Odeh, A. Oliven, S. Rauchfleisch, H. Bassan, J. Intern. Med. 229, 289 (1991).
11. J. Danesh, R. Collins, R. Peto, Lancet 350, 430 (1997); J. M. Ossewaarde, E. J. M. Feskens, A. DeVries, C. E. Vallinga, D. Kromhout, Ipidemiol. Infect. 120, 93 (1998); J. B. Muhlestein et al., J. Am. Coll. Cardiol. 27, 1555 (1996); J. A. Ramirez, Ann. Intern. Med. 125, 979 (1996); J. T. Grayston, C. C. Kuo, L. A. Campbell, E. P. Benditt, Eur. Heart J. 14 (suppl. K), 66 (1993); L. A. Campbell et al., J. Infect Dis. 172, 585 (1995); H. Miettinen et al., Eur. Heart J. 17, 682 (1996); S. Halme et al., ibid. 18, 1095 (1997); M. Odeh, A. Oliven, S. Rauchfleisch, H. Bassan, J. Intern. Med. 229, 289 (1991).
12. J. Danesh, R. Collins, R. Peto, Lancet 350, 430 (1997); J. M. Ossewaarde, E. J. M. Feskens, A. DeVries, C. E. Vallinga, D. Kromhout, Ipidemiol. Infect. 120, 93 (1998); J. B. Muhlestein et al., J. Am. Coll. Cardiol. 27, 1555 (1996); J. A. Ramirez, Ann. Intern. Med. 125, 979 (1996); J. T. Grayston, C. C. Kuo, L. A. Campbell, E. P. Benditt, Eur. Heart J. 14 (suppl. K), 66 (1993); L. A. Campbell et al., J. Infect Dis. 172, 585 (1995); H. Miettinen et al., Eur. Heart J. 17, 682 (1996); S. Halme et al., ibid. 18, 1095 (1997); M. Odeh, A. Oliven, S. Rauchfleisch, H. Bassan, J. Intern. Med. 229, 289 (1991).
13. P. Saikku et al., Lancet ii, 983 (1988); S. Gupta et al., Circulation 96, 404 (1997); H. Stiegler, S. Kolbe-Busch, Y. Fischer, M. Leschke, H. Reinauer, Lancet 351, 143 (1998).
14. P. Saikku et al., Lancet ii, 983 (1988); S. Gupta et al., Circulation 96, 404 (1997); H. Stiegler, S. Kolbe-Busch, Y. Fischer, M. Leschke, H. Reinauer, Lancet 351, 143 (1998).
15. P. Saikku et al., Lancet ii, 983 (1988); S. Gupta et al., Circulation 96, 404 (1997); H. Stiegler, S. Kolbe-Busch, Y. Fischer, M. Leschke, H. Reinauer, Lancet 351, 143 (1998).
16. T. Darville, Pediatr. Rev. 19, 85 (1998); B. Munoz and S. West, Epidemiol Rev. 19, 205 (1997); T. Stokes, J. Public Health Med. 19, 222 (1997).
17. T. Darville, Pediatr. Rev. 19, 85 (1998); B. Munoz and S. West, Epidemiol Rev. 19, 205 (1997); T. Stokes, J. Public Health Med. 19, 222 (1997).
18. T. Darville, Pediatr. Rev. 19, 85 (1998); B. Munoz and S. West, Epidemiol Rev. 19, 205 (1997); T. Stokes, J. Public Health Med. 19, 222 (1997).
19. P. M. Ridker, Circulation 97, 1671 (1998); P. Libby, D. Egan, S. Skarlatos, ibid. 96, 4095 (1997).
20. P. M. Ridker, Circulation 97, 1671 (1998); P. Libby, D. Egan, S. Skarlatos, ibid. 96, 4095 (1997).
21. N. Neu et al., J. Immunol. 139, 3630 (1987).
22. C. L. Pummerer et al., Lab. Invest. 74, 845 (1996); S. C. Smith and P. M. Allen, Proc. Natl. Acad. Sci. U.S.A. 89, 9131 (1992).
23. C. L. Pummerer et al., Lab. Invest. 74, 845 (1996); S. C. Smith and P. M. Allen, Proc. Natl. Acad. Sci. U.S.A. 89, 9131 (1992).
24. C. L. Pummerer et al., J. Clin. Invest. 97, 2057 (1996).
25. D. L. Donermeyer, K. W. Beisel, P. M. Allen, S. C. Smith, J. Exp. Med. 182, 1291 (1995).
26. 2-terminus. Peptides, dissolved in FCA (1 mg/ml) and emulsified in a 1:1 dilution with phosphate-buffered saline, were injected twice into 6-week-old BALB/c mice (50 μg of peptide per mouse) as described (8).
27. K. Bachmaier and J. M. Penninger, unpublished observation.
28. The GCG (Wisonsin Package) LOOKUP program was used to create a LIST FILE of bacterial and viral sequences from the PIR protein database. The list file was then searched with the GCG program FINDPATTERNS for the sequence pattern MAXXXST.
29. M. W. Watson, P. R. Lambden, J. S. Everson, I. N. Clarke, Microbiology 140, 2003 (1994); A. M. Coles, I. Allan, J. H. Pearce, Nucleic Acids Res. 18, 6713 (1990); L. M. de la Maza, T. J. Fielder, E. J. Carlson, B. A. Markoff, E. M. Peterson, Infect. Immun. 59, 1196 (1991).
30. M. W. Watson, P. R. Lambden, J. S. Everson, I. N. Clarke, Microbiology 140, 2003 (1994); A. M. Coles, I. Allan, J. H. Pearce, Nucleic Acids Res. 18, 6713 (1990); L. M. de la Maza, T. J. Fielder, E. J. Carlson, B. A. Markoff, E. M. Peterson, Infect. Immun. 59, 1196 (1991).
31. M. W. Watson, P. R. Lambden, J. S. Everson, I. N. Clarke, Microbiology 140, 2003 (1994); A. M. Coles, I. Allan, J. H. Pearce, Nucleic Acids Res. 18, 6713 (1990); L. M. de la Maza, T. J. Fielder, E. J. Carlson, B. A. Markoff, E. M. Peterson, Infect. Immun. 59, 1196 (1991).
32. M. W. Watson, P. R. Lambden, I. N. Clarke, Nucleic Acids Res. 18, 5300 (1990); M. W. Watson, S. al-Mahdawi, P. R. Lamden, I. N. Clarke, ibid., p. 5299.
33. M. W. Watson, P. R. Lambden, I. N. Clarke, Nucleic Acids Res. 18, 5300 (1990); M. W. Watson, S. al-Mahdawi, P. R. Lamden, I. N. Clarke, ibid., p. 5299.
34. M. Comanducci, S. Ricci, R. Cevenini, G. Ratti, Plasmid 23, 149 (1990).
35. K. Bachmaier et al., Circulation 96, 585 (1997).
36. BALB/c mice were immunized twice with ChTR1 in FCA (10), and hearts were removed 21 days after the initial immunization. Immunoperoxidase staining of histological heart sections was performed with the following antibodies to rat IgG (all purchased from Pharmingen): anti-CD11b, anti-CD4, anti-CD8α, and anti-CD45R/ B220. Binding of primary antibodies was detected as described (76). Percentages of infiltrating cells were calculated from a minimum of 1000 infiltrating cells counted on representative heart sections.
37. Supplemental web material for Fig. 2 (analysis of splenic cell populations) is available at www. sciencemag.org/feature/data/984504.shl.
38. Splenocytes were harvested 21 days after the initial immunization with FCA, ChTR1, or M7Aα, and subpopulations were analyzed by fluorescence-activated cell sorting. Specific antibodies to rat IgG (all pur-chased from Pharmingen) were as follows: anti-CD11b, anti-CD4, anti-CD8α, and anti-CD45R/B220.
39. 3H] thymidine. It should be noted that 10 days after the inital immunization, T cell reactivity is already observed, that is, at a time when no histopathological signs of myocarditis are present.
40. + phenotype.
41. K. Bachmaier et al., J. Immunol. 157, 1752 (1996).
42. Twenty-one days after the initial immunization (10), serum was collected and specific antibody production was determined by enzyme-linked immunosorbent assay (ELISA) (6). Briefly, 96-well plates were coated with 2 μg of peptide per well. Diluted mouse sera (1:100) were allowed to bind to the plates, washed, and binding was detected with horseradish peroxidase-conjugated antibody to mouse IgC (Sigma, #A-3673). Substrate (ABTS, Sigma, #A-1888) conversion was detected measuring absorbance at 405 nm.
43. A. M. Krieg et al., Nature 374, 546 (1995); H. L. Davis et al., J. Immunol. 160, 870 (1998); J. P. Messina, G. S. Gilkeson, D. S. Pisetsky, ibid. 147, 1759 (1991).
44. A. M. Krieg et al., Nature 374, 546 (1995); H. L. Davis et al., J. Immunol. 160, 870 (1998); J. P. Messina, G. S. Gilkeson, D. S. Pisetsky, ibid. 147, 1759 (1991).
45. A. M. Krieg et al., Nature 374, 546 (1995); H. L. Davis et al., J. Immunol. 160, 870 (1998); J. P. Messina, G. S. Gilkeson, D. S. Pisetsky, ibid. 147, 1759 (1991).
46. CpG motive-containing synthetic oligodeoxynucleotides (ODNs) were derived either from C trachomatis DNA (CpG 1) or from previously reported bacterial DNA sequences (CpGs 2 and 3) (24). ODNs were phosphorothioate modified to increase their in vivo stability. ODNs (30 μg in 100 μl of 0.15 mM NaCl buffer) were administered ip at the time of the immunizations. BALB/c mice were subcutaneously immunized twice at a 7-day interval with the M7Aα peptide (50 μg per mouse) in a 1:1 emulsion with mineral oil [Freund's incomplete adjuvant (FlA)] (8, 10). Twenty-one days after the initial immunization hearts were analyzed for the presence and severity of myocarditis.
47. M. Maass, C. Bartels, P. M. Engel, U. Mamat, H. H. Sievers, J. Am. Coll. Cardiol. 31, 827 (1998); M. Maass, E. Krause, P. M. Engel, S. Kruger, Angiology 48, 699 (1997); L. A. Jackson et al., Am. J. Pathol. 150, 1785 (1997); C. C. Kuo et al., Proc. Natl. Acad. Sci. U.S.A. 92, 6911 (1995); C. A. Gaydos, J. T. Summersgill, N. N. Sahney, J. A. Ramirez, T. C. Quinn, Infect. Immun. 64, 1614 (1996); C. C. Kuo et al., J. Infect. Dis. 167, 841 (1993).
48. M. Maass, C. Bartels, P. M. Engel, U. Mamat, H. H. Sievers, J. Am. Coll. Cardiol. 31, 827 (1998); M. Maass, E. Krause, P. M. Engel, S. Kruger, Angiology 48, 699 (1997); L. A. Jackson et al., Am. J. Pathol. 150, 1785 (1997); C. C. Kuo et al., Proc. Natl. Acad. Sci. U.S.A. 92, 6911 (1995); C. A. Gaydos, J. T. Summersgill, N. N. Sahney, J. A. Ramirez, T. C. Quinn, Infect. Immun. 64, 1614 (1996); C. C. Kuo et al., J. Infect. Dis. 167, 841 (1993).
49. M. Maass, C. Bartels, P. M. Engel, U. Mamat, H. H. Sievers, J. Am. Coll. Cardiol. 31, 827 (1998); M. Maass, E. Krause, P. M. Engel, S. Kruger, Angiology 48, 699 (1997); L. A. Jackson et al., Am. J. Pathol. 150, 1785 (1997); C. C. Kuo et al., Proc. Natl. Acad. Sci. U.S.A. 92, 6911 (1995); C. A. Gaydos, J. T. Summersgill, N. N. Sahney, J. A. Ramirez, T. C. Quinn, Infect. Immun. 64, 1614 (1996); C. C. Kuo et al., J. Infect. Dis. 167, 841 (1993).
50. M. Maass, C. Bartels, P. M. Engel, U. Mamat, H. H. Sievers, J. Am. Coll. Cardiol. 31, 827 (1998); M. Maass, E. Krause, P. M. Engel, S. Kruger, Angiology 48, 699 (1997); L. A. Jackson et al., Am. J. Pathol. 150, 1785 (1997); C. C. Kuo et al., Proc. Natl. Acad. Sci. U.S.A. 92, 6911 (1995); C. A. Gaydos, J. T. Summersgill, N. N. Sahney, J. A. Ramirez, T. C. Quinn, Infect. Immun. 64, 1614 (1996); C. C. Kuo et al., J. Infect. Dis. 167, 841 (1993).
51. M. Maass, C. Bartels, P. M. Engel, U. Mamat, H. H. Sievers, J. Am. Coll. Cardiol. 31, 827 (1998); M. Maass, E. Krause, P. M. Engel, S. Kruger, Angiology 48, 699 (1997); L. A. Jackson et al., Am. J. Pathol. 150, 1785 (1997); C. C. Kuo et al., Proc. Natl. Acad. Sci. U.S.A. 92, 6911 (1995); C. A. Gaydos, J. T. Summersgill, N. N. Sahney, J. A. Ramirez, T. C. Quinn, Infect. Immun. 64, 1614 (1996); C. C. Kuo et al., J. Infect. Dis. 167, 841 (1993).
52. M. Maass, C. Bartels, P. M. Engel, U. Mamat, H. H. Sievers, J. Am. Coll. Cardiol. 31, 827 (1998); M. Maass, E. Krause, P. M. Engel, S. Kruger, Angiology 48, 699 (1997); L. A. Jackson et al., Am. J. Pathol. 150, 1785 (1997); C. C. Kuo et al., Proc. Natl. Acad. Sci. U.S.A. 92, 6911 (1995); C. A. Gaydos, J. T. Summersgill, N. N. Sahney, J. A. Ramirez, T. C. Quinn, Infect. Immun. 64, 1614 (1996); C. C. Kuo et al., J. Infect. Dis. 167, 841 (1993).
53. T. C. Moazed, C. Kuo, J. T. Grayston, L. A. Campbell, J. Infect. Dis. 175, 883 (1997); J. B. Muhlestein et al., Circulation 97, 633 (1998); I. W. Fong et al., J. Clin. Microbiol. 35, 48 (1997); T. C. Moazed, C. Kuo, D. L. Patton, J. T. Grayston, L. A. Campbell, Am. J. Pathol. 148, 667 (1996).
54. T. C. Moazed, C. Kuo, J. T. Grayston, L. A. Campbell, J. Infect. Dis. 175, 883 (1997); J. B. Muhlestein et al., Circulation 97, 633 (1998); I. W. Fong et al., J. Clin. Microbiol. 35, 48 (1997); T. C. Moazed, C. Kuo, D. L. Patton, J. T. Grayston, L. A. Campbell, Am. J. Pathol. 148, 667 (1996).
55. T. C. Moazed, C. Kuo, J. T. Grayston, L. A. Campbell, J. Infect. Dis. 175, 883 (1997); J. B. Muhlestein et al., Circulation 97, 633 (1998); I. W. Fong et al., J. Clin. Microbiol. 35, 48 (1997); T. C. Moazed, C. Kuo, D. L. Patton, J. T. Grayston, L. A. Campbell, Am. J. Pathol. 148, 667 (1996).
56. T. C. Moazed, C. Kuo, J. T. Grayston, L. A. Campbell, J. Infect. Dis. 175, 883 (1997); J. B. Muhlestein et al., Circulation 97, 633 (1998); I. W. Fong et al., J. Clin. Microbiol. 35, 48 (1997); T. C. Moazed, C. Kuo, D. L. Patton, J. T. Grayston, L. A. Campbell, Am. J. Pathol. 148, 667 (1996).
57. M. Odeh, A. Oliven, S. Rauchfleisch, H. Bassan, J. Intern. Med. 229, 289 (1991); J. T. Grayston, C. H. Mordhorst, S. P. Wang, J. Am. Med. Assoc. 246, 2823 (1981); C. Y. Tong, F. Potter, E. Worthington, P. Mullins, Lancet 346, 710 (1995); L. Wesslen et al., ibid. 340, 427 (1992); F. Diaz and J. Collazos, Scand. J. Infect. Dis. 29, 93 (1997).
58. M. Odeh, A. Oliven, S. Rauchfleisch, H. Bassan, J. Intern. Med. 229, 289 (1991); J. T. Grayston, C. H. Mordhorst, S. P. Wang, J. Am. Med. Assoc. 246, 2823 (1981); C. Y. Tong, F. Potter, E. Worthington, P. Mullins, Lancet 346, 710 (1995); L. Wesslen et al., ibid. 340, 427 (1992); F. Diaz and J. Collazos, Scand. J. Infect. Dis. 29, 93 (1997).
59. M. Odeh, A. Oliven, S. Rauchfleisch, H. Bassan, J. Intern. Med. 229, 289 (1991); J. T. Grayston, C. H. Mordhorst, S. P. Wang, J. Am. Med. Assoc. 246, 2823 (1981); C. Y. Tong, F. Potter, E. Worthington, P. Mullins, Lancet 346, 710 (1995); L. Wesslen et al., ibid. 340, 427 (1992); F. Diaz and J. Collazos, Scand. J. Infect. Dis. 29, 93 (1997).
60. M. Odeh, A. Oliven, S. Rauchfleisch, H. Bassan, J. Intern. Med. 229, 289 (1991); J. T. Grayston, C. H. Mordhorst, S. P. Wang, J. Am. Med. Assoc. 246, 2823 (1981); C. Y. Tong, F. Potter, E. Worthington, P. Mullins, Lancet 346, 710 (1995); L. Wesslen et al., ibid. 340, 427 (1992); F. Diaz and J. Collazos, Scand. J. Infect. Dis. 29, 93 (1997).
61. M. Odeh, A. Oliven, S. Rauchfleisch, H. Bassan, J. Intern. Med. 229, 289 (1991); J. T. Grayston, C. H. Mordhorst, S. P. Wang, J. Am. Med. Assoc. 246, 2823 (1981); C. Y. Tong, F. Potter, E. Worthington, P. Mullins, Lancet 346, 710 (1995); L. Wesslen et al., ibid. 340, 427 (1992); F. Diaz and J. Collazos, Scand. J. Infect. Dis. 29, 93 (1997).
62. Supplemental web material for Fig. 3 (arterial wall thickness ratios) is available at www.sciencemag.org/ feature/data/984504.shl.
63. For the morphometrical analysis of arteries, inner and outer diameters of individual arteries were measured and the ratio between wall thickness (outer diameter minus inner diameter) and outer diameter was calculated [T. Matsusaka et al., J. Clin. Invest. 98, 1867 (1996)]. At least five arteries with a minimum inner diameter of 50 μm were analyzed per individual heart.
64. 7 IFU of C. trachomatis MoPn.
65. T. C. Quinn et al., J. Am. Med. Assoc. 276, 1737 (1996).
66. Z.-S. Zhao, F. Granucci, L. Yeh, P. A. Schaffer, H. Cantor, Science 279, 1344 (1998); N. K. Maclaren and M. A. Alkinson, Mol. Med. Today 3, 76 (1997); J. F. Bach, Endocr. Rev. 15, 516 (1994); M. G. von Herrath and M. B. Oldstone, Curr. Opin. Immunol. 8, 878 (1996); P. S. Ohashi, ibid., p. 808.
67. Z.-S. Zhao, F. Granucci, L. Yeh, P. A. Schaffer, H. Cantor, Science 279, 1344 (1998); N. K. Maclaren and M. A. Alkinson, Mol. Med. Today 3, 76 (1997); J. F. Bach, Endocr. Rev. 15, 516 (1994); M. G. von Herrath and M. B. Oldstone, Curr. Opin. Immunol. 8, 878 (1996); P. S. Ohashi, ibid., p. 808.
68. Z.-S. Zhao, F. Granucci, L. Yeh, P. A. Schaffer, H. Cantor, Science 279, 1344 (1998); N. K. Maclaren and M. A. Alkinson, Mol. Med. Today 3, 76 (1997); J. F. Bach, Endocr. Rev. 15, 516 (1994); M. G. von Herrath and M. B. Oldstone, Curr. Opin. Immunol. 8, 878 (1996); P. S. Ohashi, ibid., p. 808.
69. Z.-S. Zhao, F. Granucci, L. Yeh, P. A. Schaffer, H. Cantor, Science 279, 1344 (1998); N. K. Maclaren and M. A. Alkinson, Mol. Med. Today 3, 76 (1997); J. F. Bach, Endocr. Rev. 15, 516 (1994); M. G. von Herrath and M. B. Oldstone, Curr. Opin. Immunol. 8, 878 (1996); P. S. Ohashi, ibid., p. 808.
70. Z.-S. Zhao, F. Granucci, L. Yeh, P. A. Schaffer, H. Cantor, Science 279, 1344 (1998); N. K. Maclaren and M. A. Alkinson, Mol. Med. Today 3, 76 (1997); J. F. Bach, Endocr. Rev. 15, 516 (1994); M. G. von Herrath and M. B. Oldstone, Curr. Opin. Immunol. 8, 878 (1996); P. S. Ohashi, ibid., p. 808.
71. J. B. Zabriskie and J. E. Friedman, Adv. Exp. Med. Biol. 161, 457 (1983); M. B. Oldstone, Cell 50, 819 (1987); C. A. Janeway, Immunity 8, 391 (1998); M. S. Horwitz et al., Nature Med. 4, 781 (1998).
72. J. B. Zabriskie and J. E. Friedman, Adv. Exp. Med. Biol. 161, 457 (1983); M. B. Oldstone, Cell 50, 819 (1987); C. A. Janeway, Immunity 8, 391 (1998); M. S. Horwitz et al., Nature Med. 4, 781 (1998).
73. J. B. Zabriskie and J. E. Friedman, Adv. Exp. Med. Biol. 161, 457 (1983); M. B. Oldstone, Cell 50, 819 (1987); C. A. Janeway, Immunity 8, 391 (1998); M. S. Horwitz et al., Nature Med. 4, 781 (1998).
74. J. B. Zabriskie and J. E. Friedman, Adv. Exp. Med. Biol. 161, 457 (1983); M. B. Oldstone, Cell 50, 819 (1987); C. A. Janeway, Immunity 8, 391 (1998); M. S. Horwitz et al., Nature Med. 4, 781 (1998).
75. We thank M. Saunders for critical reading of the manuscript; P. S. Ohashi, T. W. Mak, Y. Y. Kong, A. Oliveirados-Santos, Q. Liu, C. Pummerer, T. Sasaki, P. Liu, and I. Kozieradzki for helpful comments; and the Amgen Protein Synthesis group and C. Richardson for providing peptides and advice. K.B. is a Fellow of the Heart and Stroke Foundation of Canada. J.M.P. is supported by the Medical Research Council of Canada.